About Haier Biomedical
Haier Biomedical is a publicly listed company based in Qingdao (China) founded in 2005. Biomedical equipment and cold chain solutions are supplied globally. The company has 2,810 employees. Haier Biomedical has completed 1 acquisition, including Suzhou Kangsheng Biological. Haier Biomedical offers products and services including Biomedical Refrigerators and Laboratory Freezers. Its legal entity in India is Haite Biomedical India Private Limited (U74999DL2017PTC319946).
Company details
Haier Biomedical was established in 2005 in Qingdao, China, within the biomedical sector. Laboratory equipment, ultra-low temperature freezers, and biosafety solutions are manufactured for healthcare and research applications. Operations encompass the development and distribution of storage systems for biological samples and medical supplies. Global markets are served from the companys Chinese headquarters, with a focus on reliable cold chain logistics and lab infrastructure.
- Headquarters Qingdao, China
- Employees 2,810
- Stage Public
- SectorsHealthcare
- Website haierbiomedical.com
- Legal Name Qingdao Haier Biomedical Co., Ltd. Class A
- Indian entity revenue₹44,100
FY 2024 · -100% YoY
- Indian entity net loss-₹1.10 Cr
FY 2024 · -24883% margin
- Indian entity EBITDA-₹1.07 Cr
FY 2024 · -24256% margin
- Employee Count2,810
- Investments & Acquisitions
Associated legal entities of Haier Biomedical
Haier Biomedical operates through Haite Biomedical India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Haite Biomedical India Private Limited CIN U74999DL2017PTC319946 | Active | 29 Jun 2017 | New Delhi, Delhi | ₹0.0 Cr | 2 | View details |
Products & Services of Haier Biomedical
Haier Biomedical offers a comprehensive portfolio of products and services, including Biomedical Refrigerators and Laboratory Freezers.
Refrigerators are used for maintaining optimal temperatures for vaccines and medical supplies
Freezers are utilized for preserving biological samples in research and healthcare facilities
Board of directors of Haite Biomedical India Private Limited (Haier Biomedical)
Haite Biomedical India Private Limited is the primary company behind Haier Biomedical. The board of Haite Biomedical India Private Limited currently have 2 directors; the longest-serving is Zhanjie Liu, appointed in 2017. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Zhanjie Liu DIN 07886506 | Director | 06 Sep 2017 | 9 yrs 2 mo | Haite Biomedical India Private Limited |
| Piyush Das DIN 11054534 | Additional Director | 01 Apr 2025 | 1 yr 7 mo | Haite Biomedical India Private Limited |
IPO & Listings of Haier Biomedical
Haier Biomedical is a publicly listed company on the SSE with ticker symbol 688139 in China, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Oct 2019
- Listed onSSE: 688139
- Listed entityQingdao Haier Biomedical Co., Ltd. Class A
- Exchange sectorProducer manufacturing
- ISINCNE100003P25
- Share price33.49 CNY (-2.79% on the day) · 2026-10-14
- Market capitalisation10,903,182,384.00 CNY
- Price to earnings40.9
- EPS (diluted, trailing year)0.82 CNY
- Dividend yield0.96%
- Volume (last session)2,761,090
Financials of Haier Biomedical
Figures of Haite Biomedical India Private Limited, the primary company behind Haier Biomedical, for FY 2024. Revenue was ₹44,100 (-100% year on year). Net loss was -₹1.10 Cr (-24883% margin). EBITDA was -₹1.07 Cr (-24256% margin). Revenue has grown at a compounded annual rate of -86% over three years and -71% over five years.
- ₹44,100Revenue · FY 2024 · -100% YoY
- -₹1.10 CrNet loss · -24883% margin
- -₹1.07 CrEBITDA · -24256% margin
- ₹60.2 LakhPaid-up capital
- -86%Revenue CAGR, 3 years
- -71%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2.32B CNY | 250.7M CNY | 301.8M CNY |
| 2024 | 2.27B CNY | 366.6M CNY | 404.3M CNY |
| 2023 | 2.27B CNY | 406.1M CNY | 394.8M CNY |
| 2022 | 2.84B CNY | 600.8M CNY | 608.3M CNY |
| 2021 | 2.11B CNY | 845.0M CNY | 479.6M CNY |
Balance sheet, profit and loss, cash flow and ratios of Haite Biomedical India Private Limited are on its company page.
Detailed financial statements for Haier Biomedical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haier Biomedical
Haier Biomedical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Suzhou Kangsheng Biological.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medical consumables and laboratory equipment are developed for research applications. | Suzhou, China | 2022 | Dec 2022 | •••• |
Complete acquisition details for Haier Biomedical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Haier Biomedical
3 dated milestones of Haier Biomedical across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Haier Biomedical is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Suzhou Kangsheng Biological.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Haier Biomedical
Complete news archive for Haier Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haier Biomedical
Haier Biomedical was founded in 2005.
Haier Biomedical is headquartered in Qingdao, China. It is registered at Qingdao, Shandong, China.
Haier Biomedical has 2,810 employees.
The primary company behind Haier Biomedical, Haite Biomedical India Private Limited, reported revenue of ₹44,100 for FY 2024, down 100% year on year.
Haier Biomedical was established in 2005 in Qingdao, China, within the biomedical sector. Laboratory equipment, ultra-low temperature freezers, and biosafety solutions are manufactured for healthcare and research applications. Operations encompass the development and distribution of storage systems for biological samples and medical supplies. Global markets are served from the companys Chinese headquarters, with a focus on reliable cold chain logistics and lab infrastructure.
Haier Biomedical offers Biomedical Refrigerators and Laboratory Freezers.
Yes, Haier Biomedical is publicly traded on SSE under the ticker symbol 688139.
Haier Biomedical has made 1 acquisition, including Suzhou Kangsheng Biological.
Haier Biomedical operates through Haite Biomedical India Private Limited.
The legal entities of Haier Biomedical currently have 2 directors, including Zhanjie Liu, Piyush Das.